GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » Total Stockholders Equity

Galderma Group AG (FRA:PY30) Total Stockholders Equity : €7,439 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Total Stockholders Equity?

Galderma Group AG's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €7,439 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Galderma Group AG's Book Value per Share for the quarter that ended in Dec. 2024 was €6.27. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Galderma Group AG's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.35.


Galderma Group AG Total Stockholders Equity Historical Data

The historical data trend for Galderma Group AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Total Stockholders Equity Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Total Stockholders Equity
4,923.37 7,439.45

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity - 4,923.37 7,090.13 7,439.45

Galderma Group AG  (FRA:PY30) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Galderma Group AG's Book Value per Share for the quarter that ended in Dec. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Galderma Group AG's Debt-to-Equity for the quarter that ended in Dec. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galderma Group AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines